141 related articles for article (PubMed ID: 4708150)
1. Tuberculin reaction in cancer patients, "Mantoux release," and lymphosuppressive-stimulatory factors.
Steward AM
J Natl Cancer Inst; 1973 Mar; 50(3):625-32. PubMed ID: 4708150
[No Abstract] [Full Text] [Related]
2. Circulating carcinoembryonic antigen levels and serum suppression of phytohemagglutinin-stimulated lymphocyte DNA synthesis: an inverse correlation in the cancer patient.
Steward AM; Kupchik HZ; Zamcheck N
J Natl Cancer Inst; 1974 Jul; 53(1):3-9. PubMed ID: 4835096
[No Abstract] [Full Text] [Related]
3. The modulation of tumour-versus-host response in lung, colon, and breast cancer patients: implications for adjuvant immunochemotherapy.
Steward AM
Aust N Z J Surg; 1977 Oct; 47(5):642-7. PubMed ID: 273408
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
Cummings FJ; Heppner GH; Stolbach L; Calabresi P
Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
[No Abstract] [Full Text] [Related]
5. [Immunosuppression: a paraneoplastic syndrome].
Nagel GA
Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
[No Abstract] [Full Text] [Related]
6. [Behavior of specific blood lymphocyte types in various stages of tumor propagation].
Ruhl E; Camphausen G; Kurisummoottil C
Blut; 1971 Oct; 23(4):216-22. PubMed ID: 5123214
[No Abstract] [Full Text] [Related]
7. The effects of surgery on lymphocyte transformation in patients with cancer.
Watkins SM
Clin Exp Immunol; 1973 May; 14(1):69-76. PubMed ID: 4716104
[TBL] [Abstract][Full Text] [Related]
8. Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer.
Edwards AJ; Rowland GF; Lee MR
Lancet; 1973 Mar; 1(7805):687-9. PubMed ID: 4120489
[No Abstract] [Full Text] [Related]
9. [On the immunologic sensitizability of tumor patients].
Hegemann F
Arch Geschwulstforsch; 1968; 32(4):339-52. PubMed ID: 4308112
[No Abstract] [Full Text] [Related]
10. Clinical value of tumour-associated antigens.
Neville AM
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():119-26. PubMed ID: 4208587
[No Abstract] [Full Text] [Related]
11. Fibrinogen degradation products in serum from patients with cancer.
Carlsson S
Acta Chir Scand; 1973; 139(6):499-502. PubMed ID: 4753096
[No Abstract] [Full Text] [Related]
12. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
Kowalczyk D; Zembala M; Popiela T; Labza H
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793
[TBL] [Abstract][Full Text] [Related]
13. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters.
Wanebo HJ; Rao B; Attiyeh F; Pinsky C; Middleman P; Stearns M
Cancer; 1980 Mar; 45(5 Suppl):1254-63. PubMed ID: 7357518
[No Abstract] [Full Text] [Related]
14. Cell-mediated and humoral immune reactions to human tumours.
Baldwin RW; Embleton MJ; Jones JS; Langman MJ
Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
[No Abstract] [Full Text] [Related]
15. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
Maluish A; Halliday WJ
J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
[No Abstract] [Full Text] [Related]
16. [Carcinoembryonic antigen in oncology].
Tkacheva GA
Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310
[No Abstract] [Full Text] [Related]
17. [Pregnancy-associated alpha 2-glycoprotein (importance of its determination in malignant tumors)].
Bohn H; Bauer HW
Ric Clin Lab; 1981; 11 Suppl 2():65-72. PubMed ID: 7323618
[No Abstract] [Full Text] [Related]
18. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
Wolberg WH
Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
[No Abstract] [Full Text] [Related]
19. Carcinoembryonic antigen.
Turner MD
JAMA; 1975 Feb; 231(7):756-8. PubMed ID: 1172874
[No Abstract] [Full Text] [Related]
20. Phytohaemagglutinin-stimulated transformation of peripheral and lymph-node lymphocytes in patients with gastro-intestinal cancer.
Guillou PJ; Brennan TG; Giles GR
Br J Surg; 1973 Sep; 60(9):745-9. PubMed ID: 4741195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
